Filing Details

Accession Number:
0001209191-23-034601
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-06-05 18:29:44
Reporting Period:
2023-06-01
Accepted Time:
2023-06-05 18:29:44
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1601830 Recursion Pharmaceuticals Inc. RXRX Biological Products, (No Disgnostic Substances) (2836) 464099738
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1856081 Shafique Virani C/O Recursion Pharmaceuticals
41 S. Rio Grande Street
Salt Lake City UT 84101
Chief Business Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Disposition 2023-06-01 25,000 $8.58 161,819 No 4 S Direct
Class A Common Stock Disposition 2023-06-02 17,865 $8.93 143,954 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. Transaction is pursuant to a 10b5-1 trading plan established by the Reporting Person on March 1, 2023.
  2. Includes 1,717 shares purchased pursuant to the Issuer's Employee Stock Purchase Plan on May 22, 2023.